Impact of Highly Active Antiretroviral Therapy (HAART) on AIDS and Death in a Cohort of Vertically HIV Type 1-Infected Children: 1980–2006Claudia Palladino, María Ángeles Muñoz‐Fernández, José M. Bellón et al.|AIDS Research and Human Retroviruses|2009Cited by 27
Integrase inhibitors in children and adolescents: clinical use and resistanceDavid Torres-Fernández, Olga Afonso, Santiago Jiménez de Ory et al.|Journal of Antimicrobial Chemotherapy|2022Cited by 9
Viral Suppression, Viral Failure, and Safety Outcomes in Children and Adolescents With HIV on Dolutegravir in Europe and ThailandKaren Scott, Marc Hainaut, John O’Rourke et al.|Clinical Infectious Diseases|2025Cited by 6
Outcomes of etravirine-based antiretroviral treatment in treatment-experienced children and adolescents living with HIV in Europe and ThailandEuropean Pregnancy and Paediatric Infections Cohort Collabor, Intira Jeannie Collins, Pagakrong Lumbiganon et al.|Antiviral Therapy|2022Cited by 5
Prevalence of M184V and K65R in proviral DNA from PBMCs in HIV-infected youths with lamivudine/emtricitabine exposureSantiago Jiménez de Ory, Lola Falcón-Neyra, Carolina Beltrán-Pavez et al.|Journal of Antimicrobial Chemotherapy|2021Cited by 1